A mathematical study of the role of tbregs in breast cancer
From MaRDI portal
Publication:2676644
DOI10.1007/s11538-022-01054-yzbMath1498.92054arXiv2203.01434OpenAlexW4294124079WikidataQ113900016 ScholiaQ113900016MaRDI QIDQ2676644
Vasilis Tsilidis, Nikolaos Gialelis, Vasiliki Bitsouni
Publication date: 28 September 2022
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/2203.01434
stability analysisnumerical simulationmathematical modellingbifurcation analysiscancer immunologytumour-evoked regulatory B cell
Nonlinear ordinary differential equations and systems (34A34) Mathematical modeling or simulation for problems pertaining to biology (92-10) Pathology, pathophysiology (92C32)
Uses Software
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- The re-polarisation of M2 and M1 macrophages and its role on cancer outcomes
- Mathematical modeling of regulatory T cell effects on renal cell carcinoma treatment
- A validated mathematical model of tumor growth including tumor-host interaction, cell-mediated immune response and chemotherapy
- Mathematical model creation for cancer chemo-immunotherapy
- Modeling dynamics of cancer radiovirotherapy
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- A delay differential equation model for tumor growth
- Macrophage-tumour interactions: In vivo dynamics
- The role of the innate immune system in oncolytic virotherapy
- A mathematical model of cancer treatment by immunotherapy
- Natural killer cells recruitment in oncolytic virotherapy: a mathematical model
- Mathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response
- Mathematical modelling for the role of CD\(4^+\)T cells in tumor-immune interactions
- Mathematical model of BCG immunotherapy in superficial bladder cancer
- Interactions between the immune system and cancer: A brief review of non-spatial mathematical models
- A MATHEMATICAL MODEL OF PANCREATIC CANCER WITH TWO KINDS OF TREATMENTS
